On October 16, 2025, President Trump announced new initiatives aimed at expanding access to in vitro fertilization (IVF) and reducing fertility treatment costs. Key components of the announcement include:
- Discounted Fertility Medications: A partnership with EMD Serono will provide discounts on IVF drugs including Gonal-f, Ovidrel and Cetrotide. These medications will be available through a new government-backed platform, TrumpRX.
- Employer Fertility Benefits: The administration is issuing guidance to encourage employers to offer standalone infertility benefits, similar to dental and vision plans. However, there will be no federal mandate or subsidies for such coverage.
- FDA Fast-Tracking Drug Approval: EMD Serono’s drug Pergoveris will undergo priority review by the FDA to expedite its availability in the U.S. market.
These efforts are part of a larger goal to make fertility care more accessible and affordable nationwide in the years to come. As we await detail from the administration around the start date of these potential new programs, it’s important to note that time is a valuable resource in fertility care. If you’re experiencing infertility or struggling to build your family now, it’s important not to delay seeking help. A fertility specialist can diagnose the cause and guide you toward solutions, and many patients are able to conceive without IVF. For those who need advanced treatments, Prelude Network clinics offer financing options to make care more accessible.
Future Impact at The Prelude Network
Here’s how this could affect patients at the Prelude Network in 2026 and beyond:
- If you’re already in treatment: Your current medication plan will stay the same for now. When the new discounts begin, your clinic help you see if they apply to future cycles.
- If you’re planning IVF: Medication prices may go down in 2026. At present, TrumpRx does not have a launch date and we are unable to forecast when these medication pricing changes may come into effect.
- If your job offers insurance: More companies may begin covering IVF. Prelude can help you check if your plan includes new benefits.
- For all patients: Lower medication prices and better coverage could make IVF care easier to access for more families. Your clinic will share updates as they become available.
What to Know
- The new pricing program is not active yet. It’s expected to start in 2026. There has been no confirmed date for pricing program launch.
- The discounts only apply to specific EMD Serono medications, which are not used in all treatment types or fertility care cycles.
- Your clinic will continue to follow these updates and support patients with clear information following new developments.
For more details, see: Reuters — White House set to announce proposal seeking to make IVF more accessible
The Prelude Network is committed to helping every patient access high-quality, affordable fertility care – now and in the years to come.